NCT02208856View on ClinicalTrials.gov

Safety, Pharmacokinetics and Pharmacodynamics of Single Rising Doses Oral BIRB 796 BS in Healthy Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

December 31, 1999

Conditions
Healthy
Interventions
DRUG

BIBR 796 BS

DRUG

Placebo

OTHER

high fat standardized breakfast

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02208856 - Safety, Pharmacokinetics and Pharmacodynamics of Single Rising Doses Oral BIRB 796 BS in Healthy Human Subjects | Biotech Hunter | Biotech Hunter